Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent GlioblastomaElizabeth R. Gerstner, Tracy T. Batchelor, Dan G. Duda et al.|Clinical Cancer Research|2019Cited by 64
Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative ProjectKathleen M. Schmainda, C. Chad Quarles, Melissa Prah et al.|American Journal of Neuroradiology|2018Cited by 56
Multimodality imaging and mathematical modelling of drug delivery to glioblastomasAhmed Hamdi Boujelben, Mark A. J. Chaplain, Michael G. Watson et al.|Interface Focus|2016Cited by 47
Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO)Laura C. Bell, C. Chad Quarles, Natenael Semmineh et al.|Tomography|2019Cited by 29
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patientsElizabeth R. Gerstner, Tracy T. Batchelor, Kyrre E. Emblem et al.|Neuro-Oncology Advances|2020Cited by 17